Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity.

Literature DB >> 22303899

Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity.

Maro Ohanian, Vasiliki Leventaki, Srdan Verstovsek, Zeev Estrov, Pei Lin, Cameron Yin, Hagop Kantarjian, Yang Huh, Farhad Ravandi.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2012 PMID： 22303899 PMCID： PMC4120044 DOI： 10.3109/10428194.2012.663916

Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022

× No keyword cloud information.

13 in total

Review 1. Acute lymphoid leukemia following polycythemia vera.

Authors: M Camós; F Cervantes; S Montoto; J C Hernández-Boluda; N Villamor; E Montserrat
Journal: Leuk Lymphoma Date: 1999-01

Review 2. New mutations and pathogenesis of myeloproliferative neoplasms.

Authors: William Vainchenker; François Delhommeau; Stefan N Constantinescu; Olivier A Bernard
Journal: Blood Date: 2011-06-07 Impact factor: 22.113

3. Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology.

Authors: M Nakao; J W Janssen; T Seriu; C R Bartram
Journal: Leukemia Date: 2000-02 Impact factor: 11.528

Review 4. Oncogenes in myeloproliferative disorders.

Authors: Ayalew Tefferi; D Gary Gilliland
Journal: Cell Cycle Date: 2007-03-24 Impact factor: 4.534

5. Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

Authors: Philip A Beer; François Delhommeau; Jean-Pierre LeCouédic; Mark A Dawson; Edwin Chen; David Bareford; Rajko Kusec; Mary Frances McMullin; Claire N Harrison; Alessandro M Vannucchi; William Vainchenker; Anthony R Green
Journal: Blood Date: 2009-12-11 Impact factor: 22.113

Review 6. Stem cells and somatic cells: reprogramming and plasticity.

Authors: Zeev Estrov
Journal: Clin Lymphoma Myeloma Date: 2009

7. Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia.

Authors: A Polliack; M Prokocimer; Y Matzner
Journal: Am J Hematol Date: 1980 Impact factor: 10.047

8. In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm.

Authors: Jonathan R Lambert; Tamara Everington; David C Linch; Rosemary E Gale
Journal: Blood Date: 2009-06-18 Impact factor: 22.113

9. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.

Authors: Dani Bercovich; Ithamar Ganmore; Linda M Scott; Gilad Wainreb; Yehudit Birger; Arava Elimelech; Chen Shochat; Giovanni Cazzaniga; Andrea Biondi; Giuseppe Basso; Gunnar Cario; Martin Schrappe; Martin Stanulla; Sabine Strehl; Oskar A Haas; Georg Mann; Vera Binder; Arndt Borkhardt; Helena Kempski; Jan Trka; Bella Bielorei; Smadar Avigad; Batia Stark; Owen Smith; Nicole Dastugue; Jean-Pierre Bourquin; Nir Ben Tal; Anthony R Green; Shai Izraeli
Journal: Lancet Date: 2008-09-19 Impact factor: 79.321

10. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

Authors: Linda M Scott; Wei Tong; Ross L Levine; Mike A Scott; Philip A Beer; Michael R Stratton; P Andrew Futreal; Wendy N Erber; Mary Frances McMullin; Claire N Harrison; Alan J Warren; D Gary Gilliland; Harvey F Lodish; Anthony R Green
Journal: N Engl J Med Date: 2007-02-01 Impact factor: 91.245

5 in total

Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity.

Review 1. Acute lymphoid leukemia following polycythemia vera.

Review 2. New mutations and pathogenesis of myeloproliferative neoplasms.

3. Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology.

Review 4. Oncogenes in myeloproliferative disorders.

5. Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

Review 6. Stem cells and somatic cells: reprogramming and plasticity.

7. Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia.

8. In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm.

9. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.

10. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

1. Acute Lymphoblastic Leukemia Transformation in Polycythemia Vera: A Rare Phenomenon.

2. Acute Lymphoblastic Leukemia in the Course of Polycythemia Vera: A Case Report and Review of Literature.

3. Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

4. Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure.

5. Expression of CD markers in JAK2^V617F positive myeloproliferative neoplasms: Prognostic significance.